Theragen receives patent for spine fusion bone-growth stimulator system
Theragen Inc. has announced the issuance of a U.S. patent for the ActaStim-S, a spine fusion bone-growth stimulator system that reportedly promotes healing and encourages patient compliance during the postoperative process.
According to a press release, the ActaStim-S system is equipped with digital health data connectivity to allow for improved patient engagement and dialogue.
“Spinal fusion is a healing process, often characterized as a race to achieve solid fusion before failure of the implanted hardware,” Chris McAuliffe, CEO of Theragen and co-inventor of the ActaStim-S, said in the release. “Electrical stimulation is a clinically proven, safe and effective postoperative adjunct therapy that can help patients win that race; however, its clinical effectiveness requires regular use over several months. That's why we've taken a user-centric approach, designing a more wearable device that also offers a digital health component that gives patients the unique opportunity to engage in, follow and truly impact their own recovery,” he added.
Read more about